Rachel McMinn

Chief Executive Officer at

Neurogene, Inc.

Net worth: 43 M $ as of 31/07/2026

53 year

62 connections

Finance

Health Technology

Consumer Services

Profile

Rachel L.
McMinn is the founder of Neurogene OpCo., founded in 2018, serving as Chief Executive Officer since 2019.
Dr. McMinn is the founder of Neurogene, Inc., founded in 2018, serving as Executive Chairman & Chief Executive Officer since 2023.
Dr. McMinn is currently Director at EveryONE Medicines, Inc. since 2021.
Former positions include Director at Cowen & Co. LLC.
from 2007 to 2009, Senior Analyst at Piper Sandler & Co. (Broker), Chief Business & Strategy Officer at Intercept Pharmaceuticals, Inc. from 2014 to 2017, Principal at Banc of America Securities LLC in 2009, Analyst at Piper Sandler & Co., and Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. Education includes a doctorate from The Scripps Research Institute and an undergraduate degree from Cornell University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
8.36%	07/04/2026	1,302,474 ( 8.36% )	43 M $	31/07/2026

Rachel McMinn active positions

Companies	Position	Start
Neurogene, Inc. Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases	Chief Executive Officer	01/01/2018
EveryONE Medicines, Inc. EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Develops precision therapeutics	Director/Board Member	01/01/2021

All active positions of Rachel McMinn

Former positions of Rachel McMinn

Companies	Position	End
INTERCEPT PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/12/2017
Banc of America Securities LLC Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	30/04/2009
Cowen & Co. LLC Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	31/03/2009
Piper Sandler & Co. (Broker) Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	31/12/2006
Piper Sandler & Co. Piper Sandler & Co. Investment ManagersFinance Provides investment advice	Corporate Officer/Principal	-

See the detail of Rachel McMinn's experience

Training of Rachel McMinn

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rachel McMinn's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Cowen & Co. LLC Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Piper Sandler & Co. (Broker) Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services	Finance
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases	Health Technology
The Scripps Research Institute The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Banc of America Securities LLC Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Piper Sandler & Co. Piper Sandler & Co. Investment ManagersFinance Provides investment advice	Finance
Merrill Lynch, Pierce, Fenner & Smith, Inc. Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services	Finance
Neurogene, Inc. Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases	Health Technology
EveryONE Medicines, Inc. EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Develops precision therapeutics	Commercial Services